Bg Medicine(OTC) BGMD

BG Medicine, Inc. is focused on developing and commercializing diagnostic products for heart failure and related conditions. The company offers innovative solutions that guide patient care, aiming to improve health outcomes for individuals in the United States.

Products and Services

• BGM Galectin-3 Test for quantifying galectin-3 levels in blood
• CardioSCORE Test assessing short-term cardiovascular event risks
• Licensing agreements with major partners for automated testing solutions

Growth Outlook

• Strategic alliances with Abbott Laboratories enhance market reach
• Increasing demand for heart failure diagnostics supports growth potential
• Focus on innovative testing solutions aligns with healthcare trends

Financial Highlights

• Recent quarterly revenue of 290,000 reflects ongoing market engagement
• Cash and cash equivalents at 1,525,000 provide operational liquidity
• Gross profit margin of 71.72% indicates strong product demand

BG Medicine, Inc. operates within the medical instruments and supplies industry, emphasizing the importance of diagnostics in managing heart failure. The company's flagship products, the BGM Galectin-3 Test and CardioSCORE Test, are designed to provide critical insights into patient health, thereby facilitating timely and effective treatment decisions. The growth outlook for BG Medicine is bolstered by strategic partnerships, particularly with Abbott Laboratories, which not only enhance product distribution but also expand the company's technological capabilities. As the healthcare landscape increasingly prioritizes early diagnosis and personalized treatment, BG Medicine is well-positioned to capitalize on these trends. Financially, the company has shown resilience with a recent quarterly revenue of 290,000, reflecting its ability to maintain market presence despite challenges. The gross profit margin of 71.72% underscores the strong demand for its diagnostic solutions, while a cash position of 1,525,000 ensures that the company can continue its operations and invest in future growth initiatives. Overall, BG Medicine, Inc. presents a compelling opportunity for investors interested in the evolving field of medical diagnostics.